LSRF Surges on Policy‑Driven TCM Boom Amid Market Volatility
LSRF rides policy‑driven TCM growth amid market volatility, positioning its diverse portfolio to capture expanding demand for quality traditional medicines.
4 minutes to read
LSRF
LSRF Surges 20% as China’s New TCM Plan Boosts Traditional Medicine ETF
LSRF jumps 20% on China’s new TCM plan, backed by a state‑approved 15‑year modernisation push that boosts evidence‑driven products and market growth.
3 minutes to read